Cargando…
Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
BACKGROUND: Ov16 serology is considered a reference method for Onchocerca volvulus epidemiological mapping. Given the suboptimal sensitivity of this test and the fact that seroconversion takes more than a year after infection, additional serological tests might be needed to guide onchocerciasis elim...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350367/ https://www.ncbi.nlm.nih.gov/pubmed/30691520 http://dx.doi.org/10.1186/s13071-019-3308-z |
_version_ | 1783390440255389696 |
---|---|
author | Vlaminck, Johnny Lagatie, Ole Verheyen, Ann Dana, Daniel Van Dorst, Bieke Mekonnen, Zeleke Levecke, Bruno Stuyver, Lieven J. |
author_facet | Vlaminck, Johnny Lagatie, Ole Verheyen, Ann Dana, Daniel Van Dorst, Bieke Mekonnen, Zeleke Levecke, Bruno Stuyver, Lieven J. |
author_sort | Vlaminck, Johnny |
collection | PubMed |
description | BACKGROUND: Ov16 serology is considered a reference method for Onchocerca volvulus epidemiological mapping. Given the suboptimal sensitivity of this test and the fact that seroconversion takes more than a year after infection, additional serological tests might be needed to guide onchocerciasis elimination programmes. Recently, two linear epitopes encoded in OvMP-1 and OvMP-23 peptides were introduced as serological markers, but the observed antibody cross-reactivity in samples originating from Onchocerca volvulus non-endemic areas required further investigation. METHODS: We evaluated both peptide markers in an O. volvulus hypo-endemic setting in Jimma Town, Ethiopia using peptide ELISA. For all individuals (n = 303), the infection status with soil-transmitted helminths and Schistosoma mansoni was known. RESULTS: We found that 11 (3.6%) individuals were positive for anti-Ov16 IgG4 antibodies, while 34 (11.2%) and 15 (5.0%) individuals were positive for OvMP-1 and OvMP-23, respectively. Out of the 34 OvMP-1 positive samples, 33 were negative on the Ov16 IgG4 ELISA. Similarly, out of the 15 OvMP-23 positive samples, 14 scored negative on this reference method. No difference in seroprevalence for all three markers could be observed between uninfected individuals and individuals infected with different soil-transmitted helminths or S. mansoni. Moreover, the intensity of the response to OvMP-1, OvMP-23 or Ov16 was not significantly stronger in individuals carrying patent STH or S. mansoni infections, nor was there any correlation between the intensities of the responses to the three different antigens. CONCLUSIONS: This study demonstrates that a patent infection with either soil-transmitted helminths or S. mansoni does not lead to increased antibody recognition of both OvMP-1 and OvMP23. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-019-3308-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6350367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63503672019-02-04 Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 Vlaminck, Johnny Lagatie, Ole Verheyen, Ann Dana, Daniel Van Dorst, Bieke Mekonnen, Zeleke Levecke, Bruno Stuyver, Lieven J. Parasit Vectors Research BACKGROUND: Ov16 serology is considered a reference method for Onchocerca volvulus epidemiological mapping. Given the suboptimal sensitivity of this test and the fact that seroconversion takes more than a year after infection, additional serological tests might be needed to guide onchocerciasis elimination programmes. Recently, two linear epitopes encoded in OvMP-1 and OvMP-23 peptides were introduced as serological markers, but the observed antibody cross-reactivity in samples originating from Onchocerca volvulus non-endemic areas required further investigation. METHODS: We evaluated both peptide markers in an O. volvulus hypo-endemic setting in Jimma Town, Ethiopia using peptide ELISA. For all individuals (n = 303), the infection status with soil-transmitted helminths and Schistosoma mansoni was known. RESULTS: We found that 11 (3.6%) individuals were positive for anti-Ov16 IgG4 antibodies, while 34 (11.2%) and 15 (5.0%) individuals were positive for OvMP-1 and OvMP-23, respectively. Out of the 34 OvMP-1 positive samples, 33 were negative on the Ov16 IgG4 ELISA. Similarly, out of the 15 OvMP-23 positive samples, 14 scored negative on this reference method. No difference in seroprevalence for all three markers could be observed between uninfected individuals and individuals infected with different soil-transmitted helminths or S. mansoni. Moreover, the intensity of the response to OvMP-1, OvMP-23 or Ov16 was not significantly stronger in individuals carrying patent STH or S. mansoni infections, nor was there any correlation between the intensities of the responses to the three different antigens. CONCLUSIONS: This study demonstrates that a patent infection with either soil-transmitted helminths or S. mansoni does not lead to increased antibody recognition of both OvMP-1 and OvMP23. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-019-3308-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-28 /pmc/articles/PMC6350367/ /pubmed/30691520 http://dx.doi.org/10.1186/s13071-019-3308-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Vlaminck, Johnny Lagatie, Ole Verheyen, Ann Dana, Daniel Van Dorst, Bieke Mekonnen, Zeleke Levecke, Bruno Stuyver, Lieven J. Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 |
title | Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 |
title_full | Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 |
title_fullStr | Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 |
title_full_unstemmed | Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 |
title_short | Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 |
title_sort | patent infections with soil-transmitted helminths and schistosoma mansoni are not associated with increased prevalence of antibodies to the onchocerca volvulus peptide epitopes ovmp-1 and ovmp-23 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350367/ https://www.ncbi.nlm.nih.gov/pubmed/30691520 http://dx.doi.org/10.1186/s13071-019-3308-z |
work_keys_str_mv | AT vlaminckjohnny patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 AT lagatieole patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 AT verheyenann patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 AT danadaniel patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 AT vandorstbieke patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 AT mekonnenzeleke patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 AT leveckebruno patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 AT stuyverlievenj patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23 |